Catechol Thioethers in Parkinson's Disease
This study has been completed.
Sponsor:
Information provided by:
National Institute of Environmental Health Sciences (NIEHS)
ClinicalTrials.gov Identifier:
NCT00042692
First received: August 5, 2002
Last updated: March 22, 2006
Last verified: March 2006
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The goal of the clinical trial aim in this project is to test whether catechol thioethers can be used as biomarkers of dopaminergic neurodegeneration.
| Condition |
|---|
|
Parkinson's Disease |
| Study Type: | Observational |
| Study Design: | Additional Descriptors: Convenience Sample Observational Model: Natural History Time Perspective: Cross-Sectional Time Perspective: Prospective |
Resource links provided by NLM:
Further study details as provided by National Institute of Environmental Health Sciences (NIEHS):
Eligibility| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Criteria
First diagnosis of Parkinson's disease.
Contacts and Locations
No Contacts or Locations Provided
More Information
No publications provided
| ClinicalTrials.gov Identifier: | NCT00042692 History of Changes |
| Other Study ID Numbers: | 10196-CP-001 |
| Study First Received: | August 5, 2002 |
| Last Updated: | March 22, 2006 |
| Health Authority: | United States: Federal Government |
Keywords provided by National Institute of Environmental Health Sciences (NIEHS):
|
catechol thioethers Parkinson's disease neurodegenerative disease |
Additional relevant MeSH terms:
|
Parkinson Disease Parkinsonian Disorders Basal Ganglia Diseases Brain Diseases |
Central Nervous System Diseases Nervous System Diseases Movement Disorders Neurodegenerative Diseases |
ClinicalTrials.gov processed this record on June 17, 2013